Innovation is at the heart of the life sciences industry. BTG has the hands and minds you need to make it happen. Life science companies are facing greater challenges than ever before—everything from payer and provider consolidation to shifting patient expectations, regulatory structures, and cost pressures. Rise to the challenge with agile, responsive help from Business Talent Group’s (BTG) on-demand life science professionals.
BTG is a marketplace of consultants and experts that enables life sciences companies to fill knowledge gaps, fuel growth and innovation, and improve patient outcomes and brand performance across major segments and therapeutic areas.
Get our free guide to working with on-demand talent.
Read NowOther content in this Stream
The product development and launch cycle within pharmaceuticals, biotech, and medical devices has long made these industries a perfect fit for on-demand talent.
Explore how high-end independent talent are serving life science companies today, providing an agile source of skills and helping life science leaders keep pace in a fast-changing environment.
In this on-demand webinar, we speak with Steve Wunker—Managing Director of New Markets Advisors—about how costovation enables companies to meet, and even exceed, customers’ expectations, cheaply
A leading mid-cap genetic diagnostic company was preparing for an important product launch in the chronic kidney disease (CKD) space. The VP of marketing reached out to Business Talent Group (BTG)...
Digital health has grown and evolved rapidly in the past decade—spurred by exciting developments in AI, machine learning, and the internet of things (IoT), alongside nearly ubiquitous adoption of smar
Independent talent provide an agile source of critical skills that allow life science leaders to keep pace in a fast-changing environment.
How can pharma marketers remain effective and relevant for key customers, patients, and healthcare providers (HCPs) in the time of COVID-19?
On-demand talent is a critical resource for life science and pharma companies as they innovate to keep pace with market changes, respond to emerging health threats, and adapt to a remote environment.
In an effort to inform its Rare Diseases commercial strategy within a specific country, an F100 pharmaceutical company was looking to gain a deeper understanding of the current competitive...
As a part of its global therapeutic area (TA) health policy initiatives, a leading biopharma company needed a new and improved narrative and evidence deck to impress upon policymakers and other...
An F500 biotech company wanted to engage a consultant to work with its medical evidence, research, and innovation team to create and coordinate several projects related to the generation of...
The U.S. patient access team at an F200 biopharma leader was seeking a strong project manager who would support their market access and marketing teams with patient / HCPs promotions. The client...
In the midst of a company-wide reorganization, the Cell Therapy Market Access team at an F200 pharmaceutical company needed a value and access expert to support several projects. Looking for...
The pharmaceutical reimbursement landscape has grown increasingly complex and—thanks to an intensifying focus on improving clinical outcomes—increasingly competitive. Reimbursement was once a...
Independent consultants provide fast, efficient, and cost-effective support for market access initiatives in health economics, pricing, regulations, patient engagement, and communications.
Prescription drug affordability is a major concern in health and life science. Asif Velani and Will Wright talk about how to address it.
Affordability is a major concern in health and life science—and not just in the U.S. In 2018, total prescription drug expenditure in the U.S. is expected to top $520 billion; 52% of Americans say...
The lines are blurring between U.S. healthcare payers and providers. What does this payer/provider consolidation mean for pharma? Nothing less than a total shift in the way it does business. If...
A major biopharmaceutical company had developed a breakthrough medication that stood to dramatically disrupt the market for its therapeutic area. Expected to be approved by the FDA in the next...
Get expert advice and seasoned project managers for all your market access, value, and reimbursement initiatives.